Study: Loteprednol Etabonate Gel 0.5% Effective Against Post-Cataract Surgery Pain

Post-operative cataract patients treated with Loteprednol etabonate as a gel or vehicle four times a day for two weeks saw significant reduction in pain and inflammation, according to a study published in the Journal of Cataract & Refractive Surgery.

The double-masked parallel-group study of 406 patients with anterior chamber cell grade two or higher at 17 U.S. sites showed 30.5 percent of gel-treated patients and 16.3 percent in the vehicle group had completely recovered from ACC by day eight. By the same time, nearly three-quarters of the first group and 41.9 percent of the second had grade 0 pain. No discomfort on drop instillation was reported by 85 percent of patients.

More Articles on Ophthalmology:

San Antonio Eye Center Adds New Office
Houston Ophthalmologists Named 'Best Doctors'
Reduced-Fluence Laser Therapy For PCV Patients Improves, Maintains Visual Acuity in 2-Year Follow-Up Study

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months